Understanding the government requirement for open access studies

Graphic by Geyslein, CC BY-SA 4.0  via Wikimedia Commons

Journalists who covered medical research during the pandemic know how helpful it was that nearly all COVID-related studies were freely available upon publication. But those who have covered medical research for years also know how unusual that is.

Using medical research in journalism has long involved finding ways past paywalls for journal articles, whether it was accessed through press registration, reaching out to authors, contacting journal publishers, befriending folks with institutional logins or tapping unsanctioned repositories like Sci-Hub.

Continue reading

How and when the FDA seeks outside advice on drug approvals

C. Joseph Ross Daval, J.D, Ameet Sarpatwari, Ph.D., J.D., and Aaron S. Kesselheim, M.D., J.D., M.P.H ( from left to right)

The U.S. Food and Drug Administration could bolster public trust in medicines through greater transparency about its decisions on when to seek expert feedback and its instructions to its advisory committees, argue members of a group that monitors the agency closely. Recent papers from Harvard’s Program On Regulation, Therapeutics And Law (PORTAL) can help journalists who want to dig more deeply into the question of when and how the FDA seeks advice on drug approvals.

Continue reading

AHCJ announces 2022-23 SHERF fellows

The 2022-23 National Science-Health-Environment Reporting Fellows

Twelve journalists have been selected for the 2022-2023 National Science-Health-Environment Reporting Fellowships (SHERF).

This is the second year of the fellowship, a collaboration of AHCJ, the Council for the Advancement of Science Writing  (CASW) and the Society of Environmental Journalists (SEJ). It offers training, mentoring, and networking opportunities to early-career journalists pursuing — or a strong interest in pursuing — careers in science, health or environmental reporting, or some combination of the three —  while they continue their work.

Continue reading

Webinar: A White House Q&A on Monkeypox

Demetre Daskalakis, M.D., M.P.H.

The number of new monkeypox cases has declined since this summer, but many questions remain about symptoms, transmission, vaccines, treatments and whether the virus that causes the disease can mutate.

For health journalists covering the evolving monkeypox story, AHCJ’s webinar on Sept. 22 at noon EST provides a great opportunity to get answers to some of your questions by asking White House National Monkeypox Response Deputy Coordinator Demetre Daskalakis, M.D, M.P.H.

Continue reading

Get involved in AHCJ: Join a committee!

Photo via Canva

If you’ve been thinking about getting involved with AHCJ, now is the time!

AHCJ relies on several committees, staffed with board members and other volunteers from the membership, to help us remain relevant to health journalists, financially viable, a strong voice for openness and transparency, and, above all, an indispensable resource. 

Continue reading